Transaction · 0001980648-26-000027

Lee Chan Henry

Lee Chan Henry, SVP, GC, reported an open-market or private sale at BeOne Medicines Ltd. involving 1115.000000 shares for an estimated $418125.00. Reported holdings after the transaction were 0.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP, GC
ONCBeOne Medicines Ltd.
Filing timeOct 02
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded100%Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,115 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$358.07
Pre-filing
1mo ago +0.4%1w ago +1.9%1d ago +2.0%
Returns since
7d30d90d180d1y

ONC price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ONC since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001980648-26-000027
American Depositary Shares
Transaction date
Sep 30, 2026
Filed Oct 02, 2026, 08:53 PM · 2d delay
Shares
1.11k sh
$375.00 per share
Estimated value
-$418k
Computed from shares × price
Holdings after
0 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time.

  2. F2

    Each American Depositary Share represents 13 Ordinary Shares.

  3. F3

    The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Original filing · 0001980648-26-000027
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ONC